MoneyWorks4Me

Eiko Lifesciences - Quaterly Results

01 Nov 2025 Evaluate
The revenue zoomed 18.84% to Rs. 91.97 millions for the quarter ended September 2025 as compared to Rs. 77.39 millions during the corresponding quarter last year.The company almost doubled its revenue to Rs. 8.17 millions  from Rs. 2.08 millions in the quarter ended September 2025.OP of the company witnessed a marginal growth to 12.85 millions from 4.79 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 91.97 77.39 18.84 166.49 184.89 -9.95 324.92 279.29 16.34
Other Income 5.65 1.31 331.30 11.19 3.93 184.73 10.24 1.76 481.82
PBIDT 12.85 4.79 168.27 23.59 11.35 107.84 27.33 17.88 52.85
Interest 0.70 0.36 94.44 0.88 0.65 35.38 1.27 1.42 -10.56
PBDT 12.15 4.43 174.27 22.71 10.70 112.24 29.47 16.46 79.04
Depreciation 1.48 1.63 -9.20 2.96 3.28 -9.76 6.29 6.62 -4.98
PBT 10.67 2.80 281.07 19.75 7.42 166.17 23.18 9.84 135.57
TAX 2.50 0.72 247.22 4.65 1.87 148.66 5.77 2.32 148.71
Deferred Tax 0.22 0.26 -15.38 0.38 0.55 -30.91 1.23 1.34 -8.21
PAT 8.17 2.08 292.79 15.10 5.55 172.07 17.41 7.52 131.52
Equity 137.21 128.73 6.59 137.63 128.73 6.91 137.63 128.73 6.91
PBIDTM(%) 13.97 6.19 125.74 14.17 6.14 130.81 8.41 6.40 31.39
Peers
Company Name CMP
Godrej Industries 1021.20
SRF 2490.00
BASF India 3411.40
Pidilite Inds. 1470.00
Tata Chemicals 607.90
View more..